 | • レポートコード：MRC2303F0146 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、236ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料は、2021年に343.71百万ドルであった世界の臓器保存市場規模が、2022年に371.71百万ドルになり、2027年まで年平均8.32%で成長して555.34百万ドルに到達すると予想しています。本調査資料では、臓器保存の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、臓器種類別（心臓、腎臓、肝臓、肺）分析、ソリューション別（カストーディアルHTK、パーファデックス、ウィスコンシン大学）分析、技術別（低体温マシン灌流、常温マシン灌流、静的冷蔵）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめております。さらに、市場参入企業として、Dr. Franz Köhler Chemie GMBH、Essential pharmaceuticals、Organ Assist B.V.、Organox limited、Paragonix technologies、Shanghai Genext Medical Technology Co., Ltd、Transmedics, Inc.、Transplant biomedicals、Waters Medical Systems, LLC、XVIVO Perfusion ABなどの情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の臓器保存市場規模：臓器種類別 - 心臓の市場規模 - 腎臓の市場規模 - 肝臓の市場規模 - 肺の市場規模 ・世界の臓器保存市場規模：ソリューション別 - カストーディアルHTKの市場規模 - パーファデックスの市場規模 - ウィスコンシン大学の市場規模 ・世界の臓器保存市場規模：技術別 - 低体温マシン灌流技術の市場規模 - 常温マシン灌流技術の市場規模 - 静的冷蔵技術の市場規模 ・世界の臓器保存市場規模：地域別 - 南北アメリカの臓器保存市場規模 アメリカの臓器保存市場規模 カナダの臓器保存市場規模 ブラジルの臓器保存市場規模 ... - アジア太平洋の臓器保存市場規模 日本の臓器保存市場規模 中国の臓器保存市場規模 インドの臓器保存市場規模 韓国の臓器保存市場規模 台湾の臓器保存市場規模 ... -ヨーロッパ/中東/アフリカの臓器保存市場規模 イギリスの臓器保存市場規模 ドイツの臓器保存市場規模 フランスの臓器保存市場規模 ロシアの臓器保存市場規模 ... -その他地域の臓器保存市場規模 ・競争状況 ・企業情報 |
The Global Organ Preservation Market size was estimated at USD 343.71 million in 2021 and expected to reach USD 371.71 million in 2022, and is projected to grow at a CAGR 8.32% to reach USD 555.34 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Organ Preservation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Organ Type, the market was studied across Heart, Kidneys, Liver, and Lung.
Based on Solution, the market was studied across Custodial HTK, Perfadex, and University of Wisconsin.
Based on Technique, the market was studied across Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Static Cold Storage.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Organ Preservation market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Organ Preservation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Organ Preservation Market, including Dr. Franz Köhler Chemie GMBH, Essential pharmaceuticals, Organ Assist B.V., Organox limited, Paragonix technologies, Shanghai Genext Medical Technology Co., Ltd, Transmedics, Inc., Transplant biomedicals, Waters Medical Systems, LLC, and XVIVO Perfusion AB.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Organ Preservation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Organ Preservation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Organ Preservation Market?
4. What is the competitive strategic window for opportunities in the Global Organ Preservation Market?
5. What are the technology trends and regulatory frameworks in the Global Organ Preservation Market?
6. What is the market share of the leading vendors in the Global Organ Preservation Market?
7. What modes and strategic moves are considered suitable for entering the Global Organ Preservation Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising instances of multiple organ failure and growth in the geriatric population
5.1.1.2. Increasing prevalence of chronic diseases
5.1.1.3. Rising government & NGO initiatives to encourage organ donation
5.1.2. Restraints
5.1.2.1. High cost of preserving the organs
5.1.2.2. Less awareness among the people about the organ donation programs
5.1.3. Opportunities
5.1.3.1. Normothermic machine perfusion as advanced paradigm for organ preservation
5.1.3.2. Emergence innovative technology in the medical sector
5.1.3.3. Increasing initiatives to encourage organ donation
5.1.4. Challenges
5.1.4.1. Development of artificial organs
5.2. Cumulative Impact of COVID-19
6. Organ Preservation Market, by Organ Type
6.1. Introduction
6.2. Heart
6.3. Kidneys
6.4. Liver
6.5. Lung
7. Organ Preservation Market, by Solution
7.1. Introduction
7.2. Custodial HTK
7.3. Perfadex
7.4. University of Wisconsin
8. Organ Preservation Market, by Technique
8.1. Introduction
8.2. Hypothermic Machine Perfusion
8.3. Normothermic Machine Perfusion
8.4. Static Cold Storage
9. Americas Organ Preservation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Organ Preservation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Organ Preservation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Dr. Franz Köhler Chemie GMBH
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Essential pharmaceuticals
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Organ Assist B.V.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Organox limited
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Paragonix technologies
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Shanghai Genext Medical Technology Co., Ltd
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Transmedics, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Transplant biomedicals
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Waters Medical Systems, LLC
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. XVIVO Perfusion AB
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing